Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | NR1I3 | Q14994 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (R)Pk-11195 SCHEMBL15118334 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL7685386 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL29357086 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL12790424 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| Pk-11195 SCHEMBL29354252 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL3126094 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| (R)Pk-11195 SCHEMBL29477174 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| Pk-11195 SCHEMBL31060347 | 1.00 | TSPO (1.00) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL3046732 | 0.89 | TSPO (0.81) | TSPOMEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL3035734 | 0.89 | TSPO (0.81) | TSPOMEN1KMT2ACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019067210-A1 | COMPOSITIONS AND METHODS FOR TREATING AR-AND/OR LNCRNA-MEDIATED DISEASES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-20190071668-A1 | COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF CANCER USING SLNCR ISOFORMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-03-07 | — | — | US | claimed |
| EP-3320093-A2 | COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT PREVENTION, AND TREATMENT OF CANCER USING SLNCR ISOFORMS | Dana-Farber Cancer Institute, Inc. (US) | 2018-05-16 | — | — | EP | claimed |
| WO-2017007941-A2 | COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT PREVENTION, AND TREATMENT OF CANCER USING SLNCR ISOFORMS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-01-12 | — | — | WO | claimed |
| US-20160184461-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-06-30 | — | — | US | claimed |
| US-20140140932-A1 | Functionalized Magnetic Nanoparticles and Use in Imaging Amyloid Deposits and Neurofibrillary Tangles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-22 | — | — | US | claimed |
| EP-2699157-A2 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | The Regents of the University of California (US) | 2014-02-26 | — | — | EP | claimed |
| CN-103491870-A | Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles | UNIV CALIFORNIA | 2014-01-01 | — | — | CN | claimed |
| EP-1878443-B1 | THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | JAPAN SCIENCE & TECH AGENCY (JP) | 2012-12-12 | — | — | EP | claimed |
| WO-2012145169-A2 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-10-26 | — | — | WO | claimed |
| EP-1077702-A1 | PERIPHERAL BENZODIAZEPINE RECEPTOR LIGANDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-02-28 | — | — | EP | claimed |
| WO-2000037086-A1 | AGONISTS AND ANTAGONISTS OF PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS | SCIOS INC. (US) | 2000-06-29 | — | — | WO | claimed |
| WO-1999066958-A2 | USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1999-12-29 | — | — | WO | claimed |
| CN-1239437-A | Mitochondrial membrane stabilizer | DAIICHI SEIYAKU CO (JP) | 1999-12-22 | — | — | CN | claimed |
| WO-1999061024-A1 | PERIPHERAL BENZODIAZEPINE RECEPTOR LIGANDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1999-12-02 | — | — | WO | claimed |
| EP-0953356-A1 | MITOCHONDRIAL MEMBRANE STABILIZER | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-11-03 | — | — | EP | claimed |
| EP-0789567-A4 | A METHOD FOR TREATING VASCULAR HEADACHES | GEN HOSPITAL CORP (US) | 1999-01-13 | — | — | EP | claimed |
| US-5776946-A | Peripheral benzodiazepine receptor ligands as antiinflammatory agents | MCGEER, EDITH G. (CA) | 1998-07-07 | — | — | US | claimed |
| EP-0789567-A1 | A METHOD FOR TREATING VASCULAR HEADACHES | THE GENERAL HOSPITAL CORPORATION (US) | 1997-08-20 | — | — | EP | claimed |
| WO-1996015782-A1 | A METHOD FOR TREATING VASCULAR HEADACHES | THE GENERAL HOSPITAL CORPORATION (US) | 1996-05-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140140932-A1 | Functionalized Magnetic Nanoparticles and Use in Imaging Amyloid Deposits and Neurofibrillary Tangles | MAPT, PRNP, APP | TSPO 91/4885MEN1 293/4885KMT2A 2374/4885 |
| US-20160184461-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | MAPT, PRNP, APP | TSPO 91/4885MEN1 293/4885KMT2A 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.